We are live on
!
Find out more
LDFO
Louis-Dreyfus Family Office Portfolio holdings
AUM
$64.7M
1-Year Est. Return
21.08%
This Fund
S&P 500
This Quarter
Est. Return
-8.57%
1 Year Est. Return
-21.08%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$64.7M
AUM Growth
-$9.67M
(-13%)
Cap. Flow
-$3.29M
Cap. Flow
% of AUM
-5.09%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
6
New
–
Increased
–
Reduced
2
Closed
1
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Total International Stock ETF
VXUS
|
+$2.68M |
| 2 |
MNDT
Mandiant, Inc. Common Stock
MNDT
|
+$589K |
| 3 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$16.8K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.57% |
| 2 | Consumer Discretionary | 0.3% |
| 3 | Technology | 0% |
Similar funds
SAM
IP
KCIA
BVLP
ACK
HLOC
FFM
BI
Louis-Dreyfus Family Office's Q3 2022 Portfolio in Review
As of Q3 2022, Louis-Dreyfus Family Office held 6 positions worth $64.7M, down 13% from $74.3M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Louis-Dreyfus Family Office withdrew a net $3.29M in Q3 2022, closing 1 position and reducing 2 holdings. Its most notable exit was Mandiant, Inc. Common Stock, an estimated $589K position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 2.6% of assets, down from 3.3% a quarter earlier, followed by Consumer Discretionary and Technology.
- Louis-Dreyfus Family Office's biggest Q3 2022 reduction was Vanguard Total International Stock ETF, cutting an estimated $2.68M.
- Louis-Dreyfus Family Office fully exited Mandiant, Inc. Common Stock in Q3 2022, selling an estimated $589K.
- Louis-Dreyfus Family Office's ten largest holdings make up 100% of its $64.7M portfolio in Q3 2022.
- Louis-Dreyfus Family Office opened 0 new positions and closed 1 in Q3 2022.
- Louis-Dreyfus Family Office's portfolio value fell 13% quarter-over-quarter to $64.7M.
Based on Louis-Dreyfus Family Office's 13F filing for Q3 2022, filed 10 Nov 2022.